155 related articles for article (PubMed ID: 28702826)
1. Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era.
De Felice F; Di Mino A; Grapulin L; Mistrulli ML; Musio D; Tombolini V
Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3735-3739. PubMed ID: 28702826
[TBL] [Abstract][Full Text] [Related]
2. Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.
Oehler-Jänne C; Seifert B; Lütolf UM; Ciernik IF
Radiat Oncol; 2006 Aug; 1():29. PubMed ID: 16916475
[TBL] [Abstract][Full Text] [Related]
3. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.
Baptista MJ; Garcia O; Morgades M; Gonzalez-Barca E; Miralles P; Lopez-Guillermo A; Abella E; Moreno M; Sancho JM; Feliu E; Ribera JM; Navarro JT
AIDS; 2015 Apr; 29(7):811-8. PubMed ID: 25730510
[TBL] [Abstract][Full Text] [Related]
4. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
[TBL] [Abstract][Full Text] [Related]
6. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
7. Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy alone: a case report.
Lim DH; Rhee JY; Park KW
Int J STD AIDS; 2017 Aug; 28(9):932-936. PubMed ID: 28094666
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy.
Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Gamez ME; Lukens JN; Shourbaji RA; Ryniak M; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
Anticancer Res; 2013 Dec; 33(12):5511-6. PubMed ID: 24324090
[TBL] [Abstract][Full Text] [Related]
9. Head and neck lymphomas associated with human immunodeficiency virus infection.
Carbone A; Vaccher E; Barzan L; Gloghini A; Volpe R; De Re V; Boiocchi M; Monfardini S; Tirelli U
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):210-8. PubMed ID: 7840930
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
11. Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma.
Yu JI; Nam H; Ahn YC; Kim WS; Park K; Kim SJ
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):507-12. PubMed ID: 20056353
[TBL] [Abstract][Full Text] [Related]
12. Good tolerance and long-term complete remission after definitive intensity-modulated radiotherapy for locally advanced head and neck cancer in a patient with human immunodeficiency virus infection: A case report and literature review.
Chen WY; Kuo SH; Shen CW; Huang BS; Lan KH; Liang HK; Wang CW
Head Neck; 2015 Dec; 37(12):E186-90. PubMed ID: 25821193
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
[TBL] [Abstract][Full Text] [Related]
14. Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.
Dorth JA; Prosnitz LR; Broadwater G; Diehl LF; Beaven AW; Coleman RE; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):762-7. PubMed ID: 22420972
[TBL] [Abstract][Full Text] [Related]
15. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
[TBL] [Abstract][Full Text] [Related]
16. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of head-and-neck radiation therapy in human immunodeficiency virus-positive patients.
Sanfilippo NJ; Mitchell J; Grew D; DeLacure M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1375-9. PubMed ID: 20097488
[TBL] [Abstract][Full Text] [Related]
18. Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.
Mian M; Ferreri AJ; Rossi A; Conconi A; Tsang R; Gospodarowicz MK; Oldani E; Federico M; Luminari S; Pogliani EM; Rossini F; Cabrera ME; Martelli M; Gutierrez-Garcia G; Busetto M; Cavalli F; Zucca E; Rambaldi A; Cortelazzo S;
Leuk Lymphoma; 2013 Jan; 54(1):62-8. PubMed ID: 22784364
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
20. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.
Johnston PB; LaPlant B; McPhail E; Habermann TM; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Witzig TE
Lancet Haematol; 2016 Jul; 3(7):e309-16. PubMed ID: 27374464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
